Flector Tissugel®: Efficacy in patients with epicondylitis;Flector Tissugel®: Efficacité chez des patients souffrant d'épicondylalgies

Journal de Traumatologie du Sport

Volumn 20, Issue 3 SUPPL. 1, 2003, Pages

  Jenoure, P J ^a  

^a Clin Rennbahn Orthopedie Med Sport   (Switzerland)

Author keywords

Diclopfenac patch; Epicondylitis; Non steroidal anti inflammatory drug; Overload injury; Pain; Sports injury

Indexed keywords

DICLOFENAC DERIVATIVE; DICLOFENAC EPOLAMINE; FLECTOR TISSUGEL; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; EPICONDYLITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SPORTS MEDICINE; STATISTICAL SIGNIFICANCE; SWITZERLAND; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 0142061516     PISSN: 0762915X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Simons-Morton DG. Physical activity, fitness, and blood pressure. In "Hypertension primer" 2nd edition. Izzo JL & Black HR. Eds. Council on High Blood Pressure Research. American Heart Association. 1999. pp 259-262.
2. Oppert JM, Balarac N. Activité physique et prise en charge des patients obèses. Ann. Endocrinol, 2001, 62 : lS37-1S42.
3. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus. A meta-analysis of controlled clinical trials. JAMA, 2001, 286 : 1218-1227.
4. Steinbeck KS. The importance of physical activity in the prevention of overweight and obesity in childhood: a review and an opinion. Obes Rev, 2001, 2: 117-130.
5. Gautier JF, Mauvais-Jarvis F. Activité physique et insulinosensibilité. Diabetes Metab, 2001, 27 : 255-260.
6. Tall AR. Exercise to reduce cardiovascular risk. How much is enough? N Engl J Med, 2002, 347: 1522-1524.
7. Oppert JM. Activité physique et maladies de la nutrition. Les enjeux. Cah Nutr Diet, 2002, 37 : 231-234.
8. Jenoure PJ, Feinstein R, Segesser B. Prévention et sport. In « Hexagone ». Roche Ed. Basel. 1987 (Vol. 2). pp 11-19.
9. Allander E. Prevalence, incidence and remission rates of some common rheumatic diseases and syndromes. Scand J Rheumatol, 1974, 3 : 145-153.
10. Hamilton PG. The prevalence of humeral epicondylitis: a survey in general practice. J R Coll Gen Pract, 1986, 36 : 464-465.
11. Bouchacourt R. Tendinites et autres rhumatismes abarticulaires. Dossiers de Médecine Pratique. Paris. 1995. 98 pages.
12. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitive systematic review of topically applied non-steroidal anti-inflammatory drugs. Br Med J, 1998, 316 : 333-338.
13. Calabro JJ, Ehrlich GE Eds. Inflammatory disease and the role of diclofenac sodium. Am J Med, 1996, 80 (Suppl. 4B) : 1-87.
14. Jenoure PJ, Segesser B, Lüthi U, Gremoin G. A trial with diclofenac HEP plaster as topical treatment in minor sport injuries. Drugs Exptl Clin Res, 1993, 19 : 129-137.
15. Jenoure PJ, Rostan A, Gremion G et al. Studio multicentrico controllato in doppio cieco su diclofenac Tissugel plaster in pazienti con epicondilite. Med Sport, 1997, 50: 285-292.
16. Huskisson EC. Measurement of pain. Lancet, 1974, 2 : 1127-1131.
17. Galer BS, Rowbotham M, Perander J, Devers A, Friedman E. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage, 2000, 19 : 287-294.
18. Affaitati G, Vecchiet F, Lerza R et al. Effects of topical diclofenac (DHEP plaster) on skin, subcutis and muscle pain threshold in subjects without spontaneous pain. Drugs Exptl Clin Res, 2001, 27 : 69-76.
19. Fries JF, Williams CA, Bloch DA. The relative toxicity of non-steroidal antiinflammatory drugs. Arthritis Rheum, 1991, 34: 1353-1360.